Trial Profile

Effectiveness and safety of silodosin in the treatment of LUTS in patients with benign prostatic hyperplasia: a European phase IV clinical study (the Silodosin in Real-life Evaluation study)

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 13 Jan 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Silodosin (Primary)
Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
Focus Therapeutic Use
Acronyms SIRE
Sponsors Recordati

Most Recent Events

15 Apr 2014 Results presented at the 29th Congress of the European Association of Urology.
02 Jan 2013 Planned end date changed from 17 Nov 2012 to 1 Aug 2013 as reported by ClinicalTrials.gov.
02 Jan 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health: NCT01757769).

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com